About this episode

This episode discusses strategies for navigating expanded access in treating pediatric oncology.

Matthew Kutny, MD, University of Alabama, Birmingham, AL, Julie Guillot, Pediatric AML parent, global advocate, and Blood Cancer United Volunteer, and Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC Recorded on February 19, 2026 Matthew Kutny, MD Professor of Pediatrics Director, Leukemia, Lymphoma and Histiocytosis Program Director, Pediatric Clinical Trials Office Institutional Principal Investigator, Children’s Oncology Group (NCI NCTN) Pediatric Hematology and Oncology University of Alabama at Birmingham Birmingham, AL Julie Guillot Pediatric AML parent, global advocate, and Blood Cancer United Volunteer Kelly Laschinger, MSN, RN, CPNP, CPHON Director, Clinical Trial Support Center Blood Cancer United Washington, DC In this episode, Dr. Matthew Kutny from the University of Alabama, and Kelly Laschinger, CPNP and Julie Guillot from Blood Cancer United, break down what clinicians and families need to know about Expanded Access (EA), also known as Compassionate Use, in treating pediatric oncology patients. They clarify key terms, outline when EA should be considered, and walk through how the process works in real-world practice. Their conversation…

Keywords

• pediatric AML
• advocacy
• clinical trials

More episodes of Treating Blood Cancers

• Driving Progress in AML · April 23, 2026 · 34 min
• Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment · April 13, 2026 · 34 min
• Optimizing Outcomes in Myeloma · March 24, 2026 · 40 min
• What’s New and What’s Next in CLL · February 17, 2026 · 39 min
• Guiding Fertility Care for Adolescents and Young Adults · February 4, 2026 · 38 min
• Building Resilience: Burnout & Compassion Fatigue Tools for HCPs · January 23, 2026 · 37 min

Explore listener stats, chart rankings, contacts and more on the Treating Blood Cancers podcast page.